Softbio Pharma Private Limited
About Softbio Pharma Private Limited
Data last updated:
Softbio Pharma Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the service-based operations segment of the business services sector. It was incorporated on 06 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC315649. Its GSTIN is 07AAYCS4639Q1Z4 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nirmal Devi Vashisth and Neeraj Vashisth.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at J – 1/144 Khirkee Extension Adjoining Krishna Temple Malviya Nagar, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.04 Lakh. For the same year it recorded a net profit of ₹18,402 (net margin 1.5%) and EBITDA of ₹18,402 (EBITDA margin 1.5%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressJ – 1/144 Khirkee Extension Adjoining Krishna Temple Malviya Nagar, New Delhi, Delhi, India – 110017
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Softbio Pharma Private Limited
The main business activity of Softbio Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Softbio Pharma Private Limited FY 2025 filings available
Softbio Pharma Private Limited reported revenue of ₹12.04 Lakh for FY 2025.
Financial Statement Summary of Softbio Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹18,402 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹18,402 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Softbio Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Softbio Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Softbio Pharma Private Limited
Softbio Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Scientific research and development). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Insar Healthcare Private Limited | ₹12.17 Lakh (FY 2024) | •••• | •••• | 62620.0% | •••• | Thane, Maharashtra, India |
| Caropet Technologies Private Limited | ₹12.06 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Zazu Wildlife Technologies Private Limited | ₹12.05 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Bangalore, Karnataka, India |
| Indian Mental Health Services Private Limited | ₹12.04 Lakh (FY 2021) | •••• | •••• | 58.0% | •••• | Pune, Maharashtra, India |
| Iota Diagnostic Private Limited | ₹12.04 Lakh (FY 2024) | •••• | •••• | 4591.0% | •••• | Gandhinagar, Gujarat, India |
| Softbio Pharma Private Limited this company | ₹12.04 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Embedite Private Limited | ₹12.03 Lakh (FY 2025) | •••• | •••• | 97.0% | •••• | Thiruvananthapuram, Kerala, India |
| Centre for Integrated Socio-Economic Development and Environment Research | ₹12.02 Lakh (FY 2021) | •••• | •••• | 600.0% | •••• | New Delhi, Delhi, India |
| Humoral Biological Private Limited | ₹12 Lakh (FY 2024) | •••• | •••• | •••• | Faridabad, Haryana, India | |
| Blue Orbit Research Private Limited | ₹11.99 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Sheoganj, Rajasthan, India |
| Relaybio Private Limited | ₹11.97 Lakh (FY 2025) | •••• | •••• | 22.0% | •••• | Tiruppur, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Softbio Pharma by revenue in the same principal business activity (Scientific research and development), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Softbio Pharma Private Limited
Softbio Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmal Devi Vashisth | Director | 06 Apr 2017 | 9 Years 6 Months | Current |
| Neeraj Vashisth | Director | 06 Apr 2017 | 9 Years 6 Months | Current |
Ownership and Shareholding of Softbio Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Softbio Pharma Private Limited
Softbio Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Softbio Pharma Private Limited
Employment history and EPFO contributions of people linked to Softbio Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Softbio Pharma Private Limited
Softbio Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Neeraj Vashisth was appointed as Director on 06 Apr 2017.
Credit Ratings, Litigation & Regulatory Alerts for Softbio Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Softbio Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Softbio Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Softbio Pharma Private Limited
Softbio Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAYCS4639Q1Z4 | Delhi | Active | 26 Jun 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Softbio Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Softbio Pharma Private Limited
Softbio Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 06 April 2017 (9+ years old) and is registered under CIN U74999DL2017PTC315649.
Softbio Pharma reported revenue of ₹12.04 Lakh for FY 2025.
Softbio Pharma has 2 current directors:
- Nirmal Devi Vashisth - Director
- Neeraj Vashisth - Director
Softbio Pharma reported a net profit of ₹18,402 (net margin 1.5%) and EBITDA of ₹18,402 (EBITDA margin 1.5%) for FY 2025, as per its filed financial statements.
The GSTIN of Softbio Pharma is 07AAYCS4639Q1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Softbio Pharma is U74999DL2017PTC315649. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Softbio Pharma was incorporated on 06 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Softbio Pharma by revenue are Insar Healthcare Private Limited, Caropet Technologies Private Limited, Zazu Wildlife Technologies Private Limited, Indian Mental Health Services Private Limited, Iota Diagnostic Private Limited and 5 more, all in the same principal business activity (Scientific research and development).
Neeraj Vashisth was appointed as Director on 06 Apr 2017. Nirmal Devi Vashisth was appointed as Director on 06 Apr 2017.
Yes, Softbio Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Softbio Pharma is at J – 1144 Khirkee Extension Adjoining Krishna Temple Malviya Nagar, New Delhi, Delhi, India – 110017.